Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Bioinformatics›Bayesian RNA-seq Differential Expression — Bayesian DE Analysis of RNA Sequencing Data
Process / pipelineBioinformatics / omics

Bayesian RNA-seq Differential Expression — Bayesian DE Analysis of RNA Sequencing Data

Bayesian Differential Expression Analysis of RNA Sequencing Data · Also known as: Bayesian DE analysis, Bayesian RNA-seq DE, baySeq, EBSeq

Bayesian RNA-seq differential expression analysis applies hierarchical Bayesian models to RNA sequencing read-count data to identify genes whose expression levels differ significantly between biological conditions. Rather than relying solely on p-values, these methods quantify the posterior probability that a gene is differentially expressed, borrowing statistical strength across genes and naturally accommodating low sample sizes common in genomics experiments.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Bayesian RNA-seq differential expression
Bayesian GWASGene Set Enrichment Anal…Pathway Enrichment Analy…RNA-seq Differential Exp…Single-cell RNA-seq anal…Variant CallingBayesian ChIP-seq peak c…Bayesian Gene Set Enrich…Bayesian Pathway Enrichm…Bayesian Proteomics Anal…

When to use it

Use Bayesian RNA-seq DE analysis when sample sizes are small (n = 2–5 per group), when you want posterior probabilities rather than frequentist p-values, or when you need principled uncertainty quantification for downstream modelling. It is particularly valuable in studies where the cost of false positives is high (e.g., biomarker discovery) and where a biologically motivated prior on the fraction of DE genes can be specified. Do NOT use it as a simple drop-in replacement for DESeq2 or edgeR when those tools already meet your needs and sample sizes are adequate; the added complexity of hyperparameter selection and MCMC convergence diagnostics is only justified when Bayesian posterior probabilities are the intended output. It is also unsuitable when you lack the bioinformatics infrastructure to run and diagnose the model.

Strengths & limitations

Strengths
  • Directly estimates the posterior probability that each gene is differentially expressed, giving an interpretable, decision-theoretic output.
  • Borrows strength across all genes via the shared prior, improving estimates for low-count and high-variance genes common in small RNA-seq experiments.
  • Naturally handles experiments with very few replicates (n = 2–3) where frequentist dispersion estimates are unreliable.
  • Posterior fold-change estimates come with credible intervals, enabling formal uncertainty quantification rather than point-estimate comparisons.
  • Flexible model structure can be extended to multi-condition, time-series, or isoform-level DE by adjusting the indicator space.
Limitations
  • Computationally more demanding than negative binomial regression-based tools (DESeq2, edgeR) when full MCMC is used; even empirical Bayes implementations require careful hyperparameter assessment.
  • Results are sensitive to prior specification — an uninformative or misspecified prior on the fraction of DE genes can inflate or deflate the DE gene list.
  • Software ecosystems (EBSeq, baySeq) have received less active maintenance than DESeq2/edgeR, limiting access to the latest normalisation and quality-control workflows.
  • Interpretation of posterior probabilities requires Bayesian literacy that is not universal among biological collaborators or reviewers.

Frequently asked

How does Bayesian DE differ from DESeq2 or edgeR?

DESeq2 and edgeR use negative binomial generalised linear models with empirical Bayes shrinkage of dispersion estimates; they report p-values and adjusted p-values (FDR). Fully Bayesian methods such as EBSeq and baySeq instead report posterior probabilities of differential expression and control a posterior false discovery rate. Both approaches borrow strength across genes, but only the Bayesian framework yields direct probability statements about DE status for each gene.

Do I need more than two replicates for Bayesian DE analysis?

Bayesian methods perform better with low replication than frequentist alternatives because of hierarchical pooling, but they are not a substitute for biological replication. At n = 2 per group the posterior inference will have wide credible intervals and many genes will fall in an uncertain probability range. A minimum of n = 3 is strongly recommended; n = 5 or more provides substantially more reliable inference.

What prior should I use for the proportion of DE genes?

EBSeq estimates the proportion of DE genes empirically from the data itself, which makes it robust to misspecification. baySeq allows user-specified priors and can estimate them via MCMC. A reasonable biological default is to expect 5–20% of expressed genes to be DE in a typical perturbation experiment; this can be refined using pilot data or domain knowledge.

Can Bayesian DE analysis handle multi-condition experiments?

Yes. Both EBSeq and baySeq define patterns of equivalence/difference across groups: for K conditions there are 2^K − 1 possible patterns. The model assigns posterior probability to each pattern for each gene, allowing detection of condition-specific expression without pairwise decomposition. This is one of the framework's key advantages over simple two-group frequentist tests.

Is Bayesian DE suitable for single-cell RNA-seq data?

Standard implementations assume modest overdispersion and moderate zero-inflation typical of bulk RNA-seq. Single-cell RNA-seq data have extreme sparsity and zero-inflation that require dedicated models (e.g., MAST, scVI). Applying bulk-RNA Bayesian DE methods directly to single-cell data without adaptation is generally not recommended.

Sources

  1. Leng, N., Dawson, J. A., Thomson, J. A., Ruotti, V., Rissman, A. I., Smits, B. M., Haag, J. D., Gould, M. N., Stewart, R. M., & Kendziorski, C. (2013). EBSeq: An empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics, 29(8), 1035–1043. link ↗
  2. Hardcastle, T. J., & Kelly, K. A. (2010). baySeq: Empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics, 11, 422. link ↗

How to cite this page

ScholarGate. (2026, June 3). Bayesian Differential Expression Analysis of RNA Sequencing Data. ScholarGate. https://scholargate.app/en/bioinformatics/bayesian-rna-seq-differential-expression

Related methods

Bayesian GWASGene Set Enrichment AnalysisPathway Enrichment AnalysisRNA-seq Differential ExpressionSingle-cell RNA-seq analysisVariant Calling

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Bayesian GWASBioinformatics↔ compare
  • Gene Set Enrichment AnalysisBioinformatics↔ compare
  • Pathway Enrichment AnalysisBioinformatics↔ compare
  • RNA-seq Differential ExpressionBioinformatics↔ compare
  • Single-cell RNA-seq analysisBioinformatics↔ compare
  • Variant CallingBioinformatics↔ compare
Compare side by side →

Referenced by

Bayesian ChIP-seq peak callingBayesian Gene Set Enrichment AnalysisBayesian Pathway Enrichment AnalysisBayesian Proteomics Analysis

Similar methods

RNA-seq Differential ExpressionBayesian single-cell RNA-seq analysisSingle-cell RNA-seq differential expressionBayesian Pathway Enrichment AnalysisMachine learning-assisted RNA-seq differential expressionBayesian Gene Set Enrichment AnalysisDifferential single-cell RNA-seq analysisMulti-omics RNA-seq differential expression

Related reference concepts

RNA Sequencing Methods and TechnologiesRNA Sequencing and TranscriptomicsPathway Enrichment and Network AnalysisEmpirical Bayes MethodsTranscriptomics and Gene Expression AnalysisSingle-Cell and Spatial Transcriptomics

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Bayesian RNA-seq differential expression (Bayesian Differential Expression Analysis of RNA Sequencing Data). Retrieved 2026-07-20 from https://scholargate.app/en/bioinformatics/bayesian-rna-seq-differential-expression · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Kendziorski et al. (EBSeq); Hardcastle & Kelly (baySeq)
Year
2010–2013
Type
Bayesian statistical inference pipeline
DataType
RNA-seq read count matrices (integer counts per gene/transcript per sample)
Subfamily
Bioinformatics / omics
Related methods
Bayesian GWASGene Set Enrichment AnalysisPathway Enrichment AnalysisRNA-seq Differential ExpressionSingle-cell RNA-seq analysisVariant Calling
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account